Reference:USA 21 CFR Part 812 09-Apr-2025 Subpart B
From GxPlex
| Document information | |
|---|---|
| Reference | USA 21 CFR Part 812 09-Apr-2025 |
| Validity area | USA |
| Scope(s) | MD |
| Document name | 21 CFR Part 812 |
| Version / Revision | 09-Apr-2025 |
| Status | Current |
| Document type | Legal act |
| Language(s) | EN |
| Description | Title 21 —Food and Drugs
Chapter I —Food and Drug Administration, Department of Health and Human Services Subchapter H—Medical Devices Part 812 Investigational Device Exemptions https://www.ecfr.gov/current/title-21 |
| Official source | Official link |
| Restricted access | No |
| Submitted by | Florian Adragna |
| Contributors | |
| Reference Details | |
|---|---|
| Module | Module 1 — Unit 1.5.4 |
| Scope | MD |
| Document part | Subpart B |
| Language | EN |
| Original entry by | Florian Adragna |
| Contributors | |
| Tags | Regulatory submission, Requirements, Medical device, Investigational device |
Content
Subpart B—Application and Administrative Action § 812.20 Application. (a) Submission. […] (b) Contents […]
